UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The lower respiratory tract microbiome of critically ill patients with COVID-19

Scientific reports, 2021-05, Vol.11 (1), p.10103-10103, Article 10103

2021

Volltextzugriff (PDF)

In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5521-5526

2013

Volltextzugriff (PDF)

Colistin: Lights and Shadows of an Older Antibiotic

Molecules (Basel, Switzerland), 2024-06, Vol.29 (13), p.2969

2024

Volltextzugriff (PDF)

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

Antibiotics (Basel), 2022-05, Vol.11 (5), p.628

2022

Volltextzugriff (PDF)

Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient

Journal of global antimicrobial resistance., 2022-09, Vol.30, p.262-264

2022

Volltextzugriff (PDF)

The Gut Microbiota of Critically Ill Patients With COVID-19

Frontiers in cellular and infection microbiology, 2021-06, Vol.11, p.670424-670424

2021

Volltextzugriff (PDF)

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria

Antibiotics (Basel), 2023-05, Vol.12 (5), p.858

2023

Volltextzugriff (PDF)

A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol

Journal of global antimicrobial resistance., 2021-12, Vol.27, p.294-298

2021

Volltextzugriff (PDF)

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae

Antibiotics (Basel), 2023-03, Vol.12 (3), p.614

2023

Volltextzugriff (PDF)

Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy

Journal of global antimicrobial resistance., 2023-06, Vol.33, p.152-154

2023

Volltextzugriff (PDF)

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy

Infection, 2021-04, Vol.49 (2), p.333-337

2021

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia

Antibiotics (Basel), 2022-12, Vol.11 (12), p.1739

2022

Volltextzugriff (PDF)

Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp

International journal of infectious diseases, 2022-04, Vol.117, p.233-240

2022

Volltextzugriff (PDF)

Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient

International journal of infectious diseases, 2021-12, Vol.113, p.213-217

2021

Volltextzugriff (PDF)

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC -Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020

Antibiotics (Basel), 2022-11, Vol.11 (11), p.1621

2022

Volltextzugriff (PDF)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018

Antibiotics (Basel), 2021-05, Vol.10 (5), p.536

2021

Volltextzugriff (PDF)

Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy

Asian Pacific journal of tropical medicine, 2023-03, Vol.16 (3), p.139-142

2023

Volltextzugriff (PDF)

An overview of Usutu virus

Microbes and infection, 2017-07, Vol.19 (7-8), p.382-387

2017

Volltextzugriff (PDF)

Mosquito, bird and human surveillance of West Nile and Usutu viruses in Emilia-Romagna Region (Italy) in 2010

PloS one, 2012-05, Vol.7 (5), p.e38058

2012

Volltextzugriff (PDF)

Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy

Current issues in molecular biology, 2023-02, Vol.45 (3), p.1852-1859

2023

Volltextzugriff (PDF)

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates

Antibiotics (Basel), 2023-12, Vol.12 (12), p.1707

2023

Volltextzugriff (PDF)

Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023

Pathogens (Basel), 2024-06, Vol.13 (6), p.507

2024

Volltextzugriff (PDF)

Rectal screening for carbapenemase-producing Enterobacteriaceae: a proposed workflow

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.86-90

2020

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae

Journal of global antimicrobial resistance., 2023-09, Vol.34, p.268-270

2023

Volltextzugriff (PDF)

Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime-Avibactam-Based Regimens: A Report of Two Cases

Microorganisms (Basel), 2022-01, Vol.10 (1), p.154

2022

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(144)
Berichte
(5)

Sprache

Englisch
(149)

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(108)
Humans
(71)
Infectious Diseases
(66)
Microbiology
(57)
Pharmacology & Pharmacy
(34)
Anti-Bacterial Agents - Pharmacology
(22)
Microbial Sensitivity Tests
(22)
Infections
(21)
Female
(20)
Klebsiella Pneumoniae
(20)
Male
(20)
Italy - Epidemiology
(16)
Antibiotics
(15)
Italy
(15)
Patients
(15)
Adult
(14)
Aged
(14)
Animals
(14)
Pneumonia
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The lower respiratory tract microbiome of critically ill patients with COVID-19

In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator

Colistin: Lights and Shadows of an Older Antibiotic

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient

The Gut Microbiota of Critically Ill Patients With COVID-19

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria

A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae

Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia

Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp

Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC -Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018

Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy

An overview of Usutu virus

Mosquito, bird and human surveillance of West Nile and Usutu viruses in Emilia-Romagna Region (Italy) in 2010

Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates

Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023

Rectal screening for carbapenemase-producing Enterobacteriaceae: a proposed workflow

Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae

Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime-Avibactam-Based Regimens: A Report of Two Cases

Suchergebnisse filtern